Shande Tang

A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia

James B. Bussel, David J. Kuter, Louis M. Aledort et al. · Blood · 2014 · 162 citations

Medicine, Hematology, Pharmacology +14

A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors

Anthony W. Tolcher, Jordan Berlin, Jan Cosaert et al. · Cancer Chemotherapy and Pharmacology · 2017 · 101 citations · Full text

Pharmacy, Immunology, Oncology +12

Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial

Daniel P. Petrylak, Scott T. Tagawa, Manish Kohli et al. · Journal of Clinical Oncology · 2016 · 84 citations

Medicine, Oncology, Pharmacotherapy +17

Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure

Norah A. Terrault, Tarek Hassanein, Charles D. Howell et al. · Journal of Hepatology · 2014 · 83 citations

Medicine, Hematology, Internal Medicine +12

Clinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy

William J. Gradishar, Denise A. Yardley, Rachel M. Layman et al. · Clinical Cancer Research · 2015 · 74 citations · Full text

Medicine, Oncology, Pharmacology +17